Penetrance, Expressivity, and Genetic Heterogeneity in Human Genetics

Study Guide - Smart Notes

Tailored notes based on your materials, expanded with key definitions, examples, and context.

Define the terms penetrance, expressivity, and genetic heterogeneity and provide examples.
Describe genotype/phenotype correlation and provide examples.

Mutation: A change in DNA sequence that is associated with disease or abnormal phenotype.
Polymorphism: A DNA sequence variation that is common in the population and generally considered benign.

Criteria for Disease-Causing Mutation:

The inheritance of the candidate mutation must match the inheritance pattern of the disease (affected family members must have the mutation).
The candidate mutation must not be found at high frequency in the general population.
The candidate mutation must not be registered as a neutral genetic polymorphism in public genetic databases.

Penetrance is the proportion of individuals with a specific genotype who exhibit any signs or symptoms of the associated disease.
It is an "all or nothing" phenomenon—individuals either show the phenotype or they do not.
Penetrance does not refer to the severity of the disease.
Types:
- Complete penetrance: All individuals with the genotype express the phenotype.
- Incomplete (reduced) penetrance: Some individuals with the genotype do not express the phenotype.

Penetrance can be age-dependent, meaning the likelihood of expressing the phenotype increases with age.
Reduced penetrance is often seen in autosomal dominant diseases but can also occur in recessive disorders.

In autosomal dominant disorders with reduced penetrance, risk to offspring is calculated as:

Example: If penetrance is 80% and the chance of inheriting the allele is 50%, the risk is (40%).

Correlates specific mutations with the severity and/or specific features of a condition.
The effects of the mutation on protein synthesis and function are key determinants of phenotype.

Anticipation is the phenomenon where a genetic disorder presents with increased severity or earlier onset in successive generations.
Commonly seen in triplet repeat disorders due to expansion of unstable repeat sequences.
May occur more frequently with paternal or maternal transmission, depending on the disorder.

Caused by CAG repeat expansion in the HTT gene.
Autosomal dominant inheritance.
Shows age-dependent penetrance.
Alleles with 36–39 repeats: reduced penetrance; 40 or more repeats: full penetrance.

CAG Repeats	Risk/Phenotype
6–26	Normal; no risk
27–35	Intermediate; small risk to children (especially if paternally inherited)
36–39	Reduced penetrance; may develop HD, 50% risk to children
>40	Full penetrance; will develop HD, 50% risk to children

HD is a chronic neurodegenerative disorder with motor, cognitive, and psychiatric symptoms.
Onset typically in late 30s–40s, but can range from childhood to late adulthood.
Duration: 15–20 years.

Most genetic diseases vary in the degree of phenotypic expression.
Variable expressivity is the variation in severity of a disorder among individuals with the same genotype.
Distinguished from penetrance (which is all-or-nothing) and genotype-phenotype correlation (which links specific mutations to specific features).

Genetic heterogeneity refers to the phenomenon where a genetic disorder can be caused by different mutations in the same gene (allelic heterogeneity) or by mutations in different genes (locus heterogeneity).

Type	Description	Example
Allelic heterogeneity	Many mutations within a single gene cause the same phenotype	Cystic fibrosis (CFTR gene)
Locus heterogeneity	Mutations in different genes cause the same phenotype	Retinitis pigmentosa, Neurofibromatosis (NF1 & NF2), Hemophilia A & B

Neurofibromatosis (NF1 & NF2): Example of locus heterogeneity.
Retinitis pigmentosa: Can be inherited in autosomal dominant, autosomal recessive, or X-linked manner; shows both locus and allelic heterogeneity.
Hemophilia: Hemophilia A (gene F8) and Hemophilia B (gene F9) are clinically indistinguishable but caused by mutations in different genes (locus heterogeneity).
Cystic fibrosis: Marked allelic heterogeneity with over 1600 mutations in the CFTR gene.

Term	Definition	Example
Penetrance	Proportion of individuals with a genotype who express the phenotype	BRCA1/2 cancer risk
Expressivity	Variation in severity of phenotype among individuals with the same genotype	Neurofibromatosis type 1
Genetic heterogeneity	Different mutations (same or different genes) cause the same phenotype	Cystic fibrosis, Retinitis pigmentosa

Clearly distinguish between penetrance, expressivity, and genotype/phenotype correlation.
Be aware of age-dependent penetrance in genetic counseling and risk assessment.
Consider genetic heterogeneity when investigating genetic conditions, as it impacts diagnosis and management.